Atreo Launches Transformative v2.0 RTSM Platform

Shaped by Industry Leaders: Atreo's v2.0 Launches in Partnership with Top 10 Sponsors

SAN FRANCISCO, April 22, 2025 /PRNewswire/ -- Atreo, the next generation Randomization and Trial Supply Management (RTSM) provider, has released its groundbreaking v2.0 Platform. Specifically designed in collaboration with large pharmaceutical and biotech client partners, v2.0 brings unmatched RTSM configuration capabilities to sponsors and CROs.

Atreo's latest release represents yet another significant leap forward in RTSM solutions, offering unparalleled agility for even the most complex protocol designs through 100% configurable solutions.  These advancements underscore Atreo's unwavering commitment to redefining the modern RTSM delivery experience and continuous RTSM innovation, bringing life-saving drugs to market faster, while ensuring a simplified site experience.  Key v2.0 highlights include:

• Enriched User Interface: Refined UI/UX design for more intuitive workflows, prioritizing a simplified, user-friendly site experience.
• Expansion of Configurability Options: Numerous advancements of configurable RTSM options, further limiting custom coding for any builds and system changes.
• Advanced Cross-Protocol Reporting: Unprecedented program level supplies reporting, surfacing actionable insights to make data-driven decisions.
• Refined Drug Pooling Features: Configurable drug pooling capabilities enabling seamless program level inventory management.

"The launch of v2.0 marks a major milestone for Atreo, our client partners, and site users, reflecting our dedication to continuous innovation driving a simplified, high-quality experience for our global users," said Ryan Harrison, Atreo CEO.  "We're proud to provide a platform that not only addresses the unique challenges faced by large pharma but also accelerates the journey of bringing vital therapies to patients worldwide for sponsors of all sizes.  Having witnessed firsthand the downstream impact of stalled R&D efforts at companies in our field, Atreo's leadership team remains committed to delivering future releases that continually improve client and site experiences.  Our unwavering commitment also enables Atreo to overcome the scalability challenges and limitations of outdated RTSM technology, delivering curated solutions without cumbersome SDLC models, costly delays, and quality issues common of yesterday's options."

About Atreo (https://www.atreo.io/):  Atreo is a modern RTSM company, comprised of experienced clinical technology experts, that delivers next generation RTSM solutions.  Atreo helps clinical teams to modernize the RTSM experience with unmatched agility and simplicity. Atreo has solved all common RTSM challenges, offering numerous unmatched advantages with a specific emphasis on:

Speed: 1 – 2 Week RTSM build from Kickoff to Launch
Collaborative RTSM Design: RTSM built before your Kickoff Meeting
Reduced Costs:  No Cost System changes delivered within days. 

Media Contact:
Evan Hahn
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/atreo-launches-transformative-v2-0-rtsm-platform-302433974.html

SOURCE Atreo, Inc.